Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome

Cancer Letters

Volumn 239, Issue 2, 2006, Pages 234-238

  Hanks, Sandra ^a   Coleman, Kim ^a   Summersgill, Brenda ^a   Messahel, Boo ^a   Williamson, Dan ^a   Pritchard Jones, Kathryn ^a   Strefford, Jon ^b   Swansbury, John ^a   Plaja, Alberto ^c   Shipley, Janet ^a   Rahman, Nazneen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Aneuploidy; BUB1B; Mosaic variegated aneuploidy; Rhabdomyosarcoma; Wilms tumour

Indexed keywords

BUB1 RELATED PROTEIN; PROTEIN BUB1B; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 3; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GRANULAR CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MISSENSE MUTATION; NEPHROBLASTOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOMATIC MUTATION; X CHROMOSOME;

ANEUPLOIDY; CHILD; HUMANS; MOSAICISM; MUTATION; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; PROTEIN KINASES;

EID: 33745576563     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.006     Document Type: Article

References (16)

1. Bharadwaj R., and Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene 23 (2004) 2016-2027
2. Lampson M.A., and Kapoor T.M. The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat. Cell Biol. 7 (2005) 93-98
3. Hanks S., Coleman K., Reid S., Plaja A., Firth H., Fitzpatrick D., et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36 (2004) 1159-1161
4. Plaja A., Vendrell T., Smeets D., Sarret E., Gili T., Catala V., et al. Variegated aneuploidy related to premature centromere division (PCD) is expressed in vivo and is a cancer-prone disease. Am. J. Med. Genet. 98 (2001) 216-223
5. Jacquemont S., Boceno M., Rival J.M., Mechinaud F., and David A. High risk of malignancy in mosaic variegated aneuploidy syndrome. Am. J. Med. Genet. 109 (2002) 17-21
6. Brito-Babapulle V., Pomfret M., Matutes E., and Catovsky D. Cytogenetic studies on prolymphocytic leukemia, II. T cell prolymphocytic leukaemia. Blood 70 (1987) 926-931
7. Summersgill B., Goker H., Weber-Hall S., Huddart R., Horwich A., and Shipley J. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br. J. Cancer 77 (1998) 305-313
8. Ganguly A. An update on conformation-sensitive gel electrophoresis. Hum. Mutat. 19 (2002) 334-342
9. Weber-Hall S., Anderson J., McManus A., Abe S., Nojima T., Pinkerton R., et al. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridisation. Cancer Res. 56 (1996) 3220-3224
10. Pandita A., Zielenska M., Thorner P., Bayani J., Godbout R., Greenberg M., and Squire J.A. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia 1 (1999) 262-275
11. Bridge J.A., Liu J., Qualman S.J., Suijkerbuijk R., Wenger G., Zhang J., et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33 (2002) 310-321
12. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., et al. A census of human cancer genes. Nat. Rev. Cancer 4 (2004) 177-183
13. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
14. Shichiri M., Yoshinaga K., Hisatomi H., Sugihara K., and Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62 (2002) 13-17
15. Sato M., Sekido Y., Horio Y., Takahashi M., Saito H., Minna J.D., et al. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Jpn. J. Cancer Res. 91 (2000) 504-509
16. Reis R.M., Nakamura M., Masuoka J., Watanabe T., Colella S., Yonekawa Y., et al. Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas. Acta Neuropathol. (Berlin) 101 (2001) 297-304